HEMACEUTICAL
LIVE

Serial Number

97202507

Owner

NEW YORK BLOOD CENTER, INC.

Attorney

Cynthia Johnson Walden

First Use Date

Aug 13, 2024

Filing Date

Jan 4, 2022

Add to watchlist:

No watchlists yet
View on USPTO

HEMACEUTICAL Trademark

Serial Number: 97202507 • Registration: 7599939

HEMACEUTICAL is a trademark filed by NEW YORK BLOOD CENTER, INC. on January 4, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NEW YORK BLOOD CENTER, INC. (46 trademarks)

NEW YORK, NY 10021

Entity Type: 99

Trademark Details

Filing Date

January 4, 2022

Registration Date

December 10, 2024

First Use Anywhere

August 13, 2024

First Use in Commerce

August 13, 2024

Published for Opposition

February 28, 2023

Goods & Services

Venture capital fund management; venture capital advisory services; venture capital services, namely, providing financing to emerging and start-up companies; investment management

Blood bank services; tissue bank services; collection and preservation of human blood, red blood cells, plasma and bone marrow; collection and preservation of human blood, red blood cells, plasma and bone

Biomedical research and development services in the field of transfusion medicine, regenerative medicine and cellular therapy related research and clinical programs from discovery through development and to the clinic

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 10, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 6, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 6, 2024 REAP
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 15, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 15, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 14, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 14, 2024 AITU
USE AMENDMENT FILED
Sep 13, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 13, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 27, 2024 EX2G
SOU EXTENSION 2 FILED
Feb 27, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 27, 2024 EEXT
ASSIGNED TO EXAMINER
Aug 31, 2023 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 22, 2023 EXRA
SOU EXTENSION 1 GRANTED
Aug 18, 2023 EX1G
SOU EXTENSION 1 FILED
Aug 18, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 18, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 25, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 28, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 25, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 18, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 12, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 12, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jan 12, 2023 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 5, 2022 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 7, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 7, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2022 NWOS
NEW APPLICATION ENTERED
Jan 7, 2022 NWAP